Agilent's Q3 Bio-analytical Revenues Fall 8 Percent amid 27 Percent Total Revenue Decline

Bio-analytical segment revenues dipped 8 percent to $496 million, with life sciences down 5 percent to $234 million.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.